ISSN 2639-9431
Vol. 5, Issue 4, 2022September 13, 2022 EDT
Harnessing Monocytes for a Liposomal Rosiglitazone-Mediated Anti-Inflammatory Effect
Harnessing Monocytes for a Liposomal Rosiglitazone-Mediated Anti-Inflammatory Effect
Articles in Vol. 5, Issue 4, 2022
Vol. 5, Issue 4, 2022
- Nanoliposomes as Drug Delivery Systems for Antifungal TherapyShathar AlobeidatTamara Athamneh
- Harnessing Monocytes for a Liposomal Rosiglitazone-Mediated Anti-Inflammatory EffectOsnat ShvindelmanMirjam M. Nordling-DavidEtty GradGershon Golomb
- Size-dependent Lattice Contraction and Oxidation State Ratio in Nano-MnO: Potential Tunable Biomedical ApplicationsMichael M. RamsdellJenna M. PikeSyed KhalidSiu-Wai Chan
- Global Health Technologies Transforming Intellectual Property Law and World TradeIlise L. Feitshans
Shvindelman, Osnat, Mirjam M. Nordling-David, Etty Grad, and Gershon Golomb. 2022. “Harnessing Monocytes for a Liposomal Rosiglitazone-Mediated Anti-Inflammatory Effect.” Precision Nanomedicine 5 (4): 930–45. https://doi.org/10.33218/001c.38312.